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Non-tubal Ectopic Pregnancy: 
Diagnosis and Management
Adebayo A. Adeniyi and Christopher A. Enakpene
Abstract
Ectopic pregnancy is the leading cause of maternal mortality in the first 
trimester, and prompt diagnosis and intervention are essential to ameliorate 
its associated complications. A majority of ectopic pregnancies are tubal, but 
extra-tubal pregnancy may pose more challenges in diagnosis and treatment. 
Early diagnosis of extra-tubal pregnancies requires high index of suspicion using 
transvaginal ultrasound and at times complemented with the help of magnetic 
resonance imaging. Similar to tubal pregnancy, extra-tubal ectopic pregnancies 
can be treated using surgical approach via laparotomy versus laparoscopy, or 
medical intervention with methotrexate, potassium chloride and most recently, 
mifepristone and epidermal growth factor inhibitor (gefitinib). For abdominal 
and ovarian ectopic pregnancies, the best surgical approach is via laparotomy or 
laparoscopy, while for cervical ectopic pregnancy and cesarean scar pregnancy 
(CSP), initial medical treatment with methotrexate, then suction curettage 
under ultrasound guidance, or hysteroscopic resection can suffice. All patients 
with extra-tubal pregnancy should be well counseled about the associated com-
plications, fertility preserving intervention, and need for prolong monitoring 
especially those that choose medical therapy.
Keywords: cervical, ovarian, abdominal, cesarean section scar, interstitial, 
pregnancy, medical, surgical, treatment
1. Introduction
Ectopic pregnancy is defined as the implantation of a fertilized ovum outside 
the normal endometrial lining of the uterine cavity, and it accounts for 1–2% of 
all pregnancies [1, 2]. The true incidence of ectopic pregnancy is unknown but 
it accounts for 18% of women seen in the emergency room for first trimester 
vaginal bleeding, or abdominal pain, or both [3]. Moreover, ruptured ectopic 
pregnancies are responsible for 2.7% of all pregnancy-related deaths, and it is 
the leading cause of hemorrhage-related mortality [4]. About 95% of ectopic 
pregnancies occur in the oviduct or the Fallopian tube, while the remaining 
5% occur in different locations such as the cervix, ovary, abdominal cavity and 
previous uterine scar especially cesarean section scar [5]. There have also been 
reported cases of ectopic pregnancy in unusual locations such as the intrahe-
patic ectopic pregnancy.
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2. Etiology and risk factors
The risk factors for tubal ectopic pregnancy are well known, and this include 
poorly treated pelvic inflammatory disease (PID) mostly due to chlamydia and 
gonorrhea, history of ectopic pregnancy, tubal surgeries including tubal steriliza-
tion procedure, pelvic surgery and congenital anomalies of the Mullerian duct 
such as abnormally long fallopian tubes, unicornuate or bicornuate uterus. Other 
risk factors include infertility, smoking, use of intrauterine contraceptive device 
(Levonorgestrel impregnated or Copper IUD), and utero exposure to diethylstil-
bestrol. While the causes of extra-tubal pregnancy are less defined, it is clear that 
assisted reproductive techniques have contributed significantly to the incidence of 
all ectopic pregnancies especially the extra-tubal pregnancies [6].
3. Ovarian pregnancy
Ovarian ectopic is also a rare variant of extra-tubal ectopic pregnancy. It 
accounts for about 0.5% of all ectopic pregnancies [7]. The incidence of ovarian 
ectopic pregnancy after natural conception ranges from 1 in 2000 to 1 in 60,000 
deliveries and accounts for 3% of all ectopic pregnancies among intrauterine 
devices users [7]. Most ovarian ectopic pregnancy (OEP) will rupture before the 
end of the first trimester, but few cases that progressed to term have been reported.
Risk factors for ovarian ectopic pregnancy:
1.  Embryo migration related to the presence of certain conditions that cause 
fallopian tube epithelial damage that alters tubal motility [8].
2. A hindrance in the release of the ovum from the ruptured follicle [9].
3. Inflammatory thickening of the tunica albuginea [10].
4.  IUD insertion is the most significant risk factor for primary OEP in 57–90% 
of the cases [8, 9]. This is because IUD provider protection for intrauterine 
implantation, but it does not prevent ovarian implantation [11].
Criteria for diagnosis of ovarian pregnancy as described by Spiegelberg in 1878:
1. Fallopian tube on the ipsilateral (affected) side must be intact.
2.  The gestational sac must occupy the normal anatomical position of the ovary 
in the ovarian fossa (see Figure 1) [12].
3. The gestational sac is connected to the uterus by the ovarian ligament.
4.  Ovarian tissue must be found on the wall of ectopic pregnancy on histological 
examination [13].
3.1 Treatment
The classical management of ovarian pregnancies is surgical. Early bleeding for 
small lesson has been managed by ovarian wedge section or cystectomy [14]. With 
larger lesions, ovariectomy is most often performed and this can be performed 
via laparotomy or laparoscopy which can be used to excise the gestational sac, to 
perform laser ablation or use of bipolar electrocoagulation. Methotrexate has been 
used successfully to treat unruptured ovarian ectopic [15].
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4. Abdominal pregnancy
Abdominal pregnancy is almost always due to secondary implantation, with the 
primary sites being the tube, ovary or even the uterus. The conceptus result from 
tubal abortion into the peritoneal cavity or escapes through a rent in the uterine 
scar [16]. However, there have been reports of rare pseudo-abdominal pregnancies 
where women have abdominal pregnancy after hysterectomy with intact ovaries. 
This is most likely to have occurred via a fistula in the vaginal cuff in fertile women 
following total hysterectomy or via cervical canal following supracervical hysterec-
tomy. The average incidence is above 1 in 3000 pregnancies. With the used of ART, 
the incidence is found rising [17]. Primary implantation of the fertilized ovum on 
the peritoneum is so rare that its existence is questionable.
4.1 Diagnosis
The diagnostic criteria of abdominal pregnancy as described by Studdiford in 1942:
1. Both the tubes and ovaries are normal without evidence of recent injury.
2. Absence of utero-peritoneal fistula.
3. Presence of a pregnancy related exclusively to the peritoneal surface and early 
enough to eliminate the possibility of secondary implantation following pri-
mary nidation in the tube [18].
Apart from symptoms of lower abdominal pain and amenorrhea, symptoms 
of normal uterine pregnancy are often exaggerated such as nausea, vomiting, 
constipation and increased fetal movements. The fetal parts are felt easily and 
persistent abdominal attitude and position of the fetus on repeated examination 
is quite common. While abdominal high position the fetus is commonly found 
in intraperitoneal pregnancy, though the fetus may be lying low in intraliga-
mentary pregnancy. The cervix is not typically soft and is usually displaced 
Figure 1. 
Ovarian ectopic pregnancy. Transvaginal ultrasound showing a gestational sac located within the ovarian 
stroma (white arrow) [12].
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depending upon the position of the sac. Investigations done in case of suspected 
abdominal ectopic pregnancy include abdominopelvic ultrasound which shows 
absence of uterine wall around the fetus with close approximation to maternal 
abdominal wall and visualization of the uterus separately. Magnetic resonance 
imaging (MRI) can confirm the diagnosis and may be very accurate. Computed 
Tomography (CT) is diagnostic and superior to MRI [19]. CT has the risk of radia-
tion. Lateral X-ray on standing position shows superimposition of fetal shadow 
with the maternal spine shadow.
4.2 Treatment
Once the diagnosis is made the opinion is almost crystallized in favor of urgent 
laparotomy irrespective of period of gestation. The risks of continuation of 
pregnancy are; catastrophic hemorrhage, fetal death, increased fetal malforma-
tion and increased neonatal loss [20]. Thus, continuation of pregnancy for few 
weeks hoping the baby to become mature enough to survive can only be justified 
in exceptional circumstances such as a case where the pregnancy continued up 
to 30 weeks and eventually resulted in a live born baby [21]. The patient and her 
relatives should be informed about the eventuality. During the period, the patient 
should be in the hospital. The ideal surgery is to remove the entire sac, fetus, the 
placenta and the membranes. This may be achieved if the placenta is attached to a 
removable organ like uterus or broad ligament. However, if the placenta is attached 
to vital organs, it is better to take the fetus and leave behind the placenta and the 
sac after tying and cutting the umbilical cord close to the placental attachment. In 
such a situation, placental activity is to be monitored by quantitative serum βHCG 
level and ultrasound. Complete resorption of the placenta occurs through aseptic 
autolysis. Complications include secondary hemorrhage, intestinal obstruction and 
infection.
5. Other types of non-tubal pregnancy
The most notable of other extra-tubal ectopic pregnancy are cervical pregnancy, 
cesarean section scar pregnancy (CSP), interstitial pregnancy and also a recently 
reported case of intrahepatic pregnancy.
6. Cervical pregnancy
Cervical ectopic pregnancies (CEP) probably the rarest of all ectopic pregnan-
cies and it occurs in about 1:16,000 pregnancies, with implantation occurring in 
the cervical canal at or below the internal cervical os (see Figures 2 and 3) [7, 12, 
22–24]. The etiology and risk factors for cervical ectopic pregnancy are similar to 
those enumerated above, but previous overzealous uterine curettage with associ-
ated Asherman syndrome and in-vitro fertilization are probably the most impor-
tant risk factors. Previous cesarean section has also been implicated as a possible 
risk factor.
The condition is commonly confused with cervical abortion. In cervical preg-
nancy, the bleeding is painless and the uterine body lies above the distended cervix. 
Intractable bleeding following evacuation or expulsion of the products brings about 
suspicion. The morbidity and mortality are high because of profuse hemorrhage 
due to paucity of smooth muscles in the cervix, hence unable to contract to stop this 
bleeding.
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6.1 Diagnosis
Many criteria have been proposed for the diagnosis of ectopic pregnancy which 
include mostly the anatomical and histological criteria described by Rubin in 1911 
but later modified in 1983, the more practical criteria by Paalman and McElin and 
finally, the sonographic criteria by Raskin et al.
The (Rubin, 1983) anatomical and histological criteria for cervical pregnancy 
include
Figure 2. 
Early cervical ectopic pregnancy with embryonic pole. Transvaginal ultrasound shows: (1) an empty and 
normal uterine cavity and (2) a cervical ectopic pregnancy with gestational sac and an embryonic pole 
(arrows) [23].
Figure 3. 
Cervical ectopic pregnancy with no definite gestational sac. Transvaginal ultrasound showing an organized 
area with no definite gestational sac located within the posterior cervical stroma (white arrow) [24].
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1. Cervical gland must be opposite the placental attachment.
2. The placenta attachment to the cervix must be situated below the entrance of 
the uterine vessels or below the peritoneal reflections of the anterior or poste-
rior surface of the uterus.
3. The fetal elements must be absent from the corpus uteri.
Rubin criteria require a hysterectomy specimen to satisfy these criteria.
Clinical diagnostic criteria as described by Paalman and McElin (1959)
1. Uterine bleeding without cramping pain following a period of amenorrhea.
2. Soft, enlarged cervix equal or larger than the fundus, (the “hourglass” appear-
ance of uterus).
3. Products of conception entirely confined within and firmly attached endocervix.
4. A closed/ snug internal cervical os.
5. A partially opened external os.
Raskin (1978) proposed ultrasound diagnostic features but later modified by 
Timor-Tritsch et al.
1. Cervical enlargement.
2. Uterine enlargement.
3. Diffused intrauterine echoes.
4. Absence of intrauterine pregnancy.
5. Empty uterus or absence of gestational sac or embryo.
6. The entire product of conception (placenta and chorionic villi) must be located 
below the internal os and the cervical canal must be dilated and barrel shaped.
Jurkovic (1996) criteria were introduced to distinguish primary cervical ectopic 
pregnancy from an aborting intra-uterine pregnancy:
1. The “sliding sign” seen on transvaginal examination must be absent.
2. The demonstration of peri-trophoblastic blood flow to the fetus by color Dop-
pler flow must be present.
7. Cesarean scar ectopic pregnancy
Cesarean scar pregnancy (CSP) accounts for 0.04–0.05 of all pregnancies [1]. 
The prenatal diagnosis of CSP is by the presence of gestational sac at the site of the 
previous uterine incision and the presence of an empty uterine cavity and cervix, as 
well as thin myometrium adjacent to the bladder (see Figure 4) [25, 26]. Cesarean 
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scar pregnancy can be classified based on the degree of invasion of amniotic sac into 
the myometrium, gestational age at diagnosis, presence of positive fetal heart beats 
and myometrial thickness of the lower uterine segment. The management of these 
rarer forms of ectopic pregnancy is just evolving.
Diagnostic criteria of cesarean scar ectopic pregnancy:
1. Empty uterus with clearly visualized endometrium.
2. Empty cervical canal.
3. Gestational sac within the anterior portion of the lower uterine segment at the 
presumed site of the cesarean scar.
4. Thinned or absent myometrium below the gestational sac and bladder (< 5 mm 
in two-thirds of cases) [27].
8. Cornual pregnancy
One of the most intriguing of ectopic pregnancies is the cornual or interstitial 
pregnancy, though not strictly extra-tubal pregnancy. It is neither located in the 
normal endometrial cavity nor in the normal fallopian tubes, but in the proximal 
portion of the tube and within the musculature of the uterus. The discussion on 
extra-tubal pregnancy cannot be complete without pointing out the implications 
of late diagnosis or misdiagnosis of cornual pregnancy; a potentially dangerous 
ectopic pregnancy. Often times, it can be mistaking for an intrauterine pregnancy 
thereby continuing till late first trimester, about 10–12 weeks of gestation. When it 
ruptures, it can result in rapid catastrophic hemorrhage because of the involvement 
of the well-vascularized muscular myometrium, and can cause significant maternal 
morbidity or mortality.
Diagnostic criteria of cornual ectopic pregnancy, 1992 [28]:
1. An empty uterine cavity.
Figure 4. 
Cesarean section scar ectopic pregnancy. Transvaginal ultrasound with 2-D and power Doppler showing: (1) normal 
uterine cavity and endometrium, (2) gestational sac in the cesarean section scar anteriorly, and (3) the vasculature 
around the gestational sac (white arrows) [25]. (A) shows cesarean ectopic pregnancy on a gray-scale ultrasound, 
and (B) shows the same pregnancy on color Doppler showing ring of fire of vessels around the gestational sac.
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2. A chorionic sac found separated (> 1 cm) from the lateral edge of the 
uterine cavity.
3. A thin (< 5 mm) myometrial layer surrounding the chorionic sac.
9. Diagnosis of non-tubal ectopic pregnancies
9.1 Pregnancy of unknown location (PUL)
Usually, the absence of intrauterine pregnancy, adnexal mass or abnormally 
rising serum beta hCG without evidence of intrauterine gestation are not always a 
confirmation of ectopic pregnancy. In the absence of any ultrasound evidence of 
visible pregnancy, the terminology of pregnancy of unknown location (PUL) is use. 
The prevalence of PUL is between 8 and 31% and it can be influenced by the quality 
of ultrasonography in the given unit, and the experience of the ultrasonographer [29, 
30]. Even when PUL is being suspected, there is usually no place for diagnostic suction 
and curettage to determine the location of the pregnancy because this will disrupt 
a potential intrauterine pregnancy. Sometimes, some cases of PUL may evolve into 
ectopic pregnancy; tubal or non-tubal that may cause life threatening complications.
9.2 Ectopic pregnancies
Transvaginal ultrasound (TVUS) is the first line tool and the gold standard 
diagnostic apparatus of ectopic pregnancy. Ectopic pregnancy is usually diagnosed 
on TVUS as the presence of a mass with hyperechoic ring around the gestational sac 
(“bagel sign”) or a gestational sac with a fetal pole with or without cardiac activity. 
The sensitivity and specificity of TVUS in detecting ectopic pregnancy are 90.9 and 
99.9%, respectively, with positive and negative predict values of 93.5 and 99.8%, 
respectively. Another ultrasound feature of ectopic pregnancy is the trilaminar 
pattern of endometrial thickness with sensitivity of 38% and specificity of 94% for 
detecting ectopic pregnancy [31]. Magnetic resonance imaging is useful as a trou-
bleshooting tool when ultrasound is equivocal or inconclusive before intervention 
or therapy [27]. Sagittal, coronal, and transverse sections of T1- and T2-weighted 
magnetic resonance imaging sequences can be used to show the gestational sac 
embedded in the anterior lower uterine segment, better evaluate pelvic anatomy, 
improve intra-operative orientation, and assess the possibility of myometrial inva-
sion and bladder involvement [27, 32, 33]. Magnetic resonance imaging can also be 
used to measure the volume of the lesion so as to help assess whether methotrexate 
will be indicated and to predicts its success as medical intervention [27].
10. Management of non-tubal pregnancy
The management of extra-tubal ectopic pregnancy depends on the location, size 
of the gestational sac, presence of fetal heart beats and symptoms at presentation. 
The definitive management of extra-tubal ectopic pregnancy involves surgical 
extermination of the gestational sac via laparotomy, laparoscopy, hysteroscopy 
or suctional curettage under ultrasound guidance. Another advantage of surgical 
extermination is that there is confirmation of ectopic pregnancy by histological 
evidence of the presence of villi within the stroma of the affected structure.
Preservative procedures such as placement of cerclage; a pulse-string suture 
or cervical plugging have been proposed as adjunct treatment for cervical ectopic 
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pregnancy. Methotrexates therapy either systemic and /or local injections directly 
into the gestational sac or intracardiac potassium chloride injection have also been 
used especially when there is associated embryonic cardiac activity. Uterine artery 
embolization with Gelfoam has also been used successfully to control hemor-
rhage. However, hysterectomy is often required to control intractable bleeding. 
Occasionally, there may be no need for intervention due to declining serum beta 
hCG levels in asymptomatic patients; however, these patients are usually closely 
monitored to ensure spontaneous resolution of the pregnancy.
11. Medical management
11.1 Methotrexate
Methotrexate is a chemotherapeutic anti-metabolite that affects rapidly divid-
ing cells, and it is use in the treatment of cancers and connective tissues disorders 
such as rheumatoid arthritis. The use of Methotrexate in the medical manage-
ment of ectopic pregnancy has to be thoroughly given serious consideration to 
avoid inadvertent administration in patient with intrauterine pregnancy. Hence, 
careful selection of appropriate candidate for Methotrexate treatment to improve 
success rate is advised. In most instances, Methotrexate should only be given to 
patients with confirmed or presumed ectopic pregnancy who are hemodynami-
cally stable with an unruptured gestational sac. The success rate is also depen-
dent on the level of serum beta hCG because single-dose systemic Methotrexate 
had approximately 90% success rate if the initial serum hCG level is less than 
5000 mIU/ml [34].
The indications and contraindications of Methotrexate should be reviewed 
before every use. For some extra-tubal pregnancies like CSP and cervical pregnan-
cies, use of Methotrexate may be considered as the first and only option before 
surgical intervention to minimize catastrophic hemorrhage. The higher the level of 
serum beta hCG, the more likely the failure rate of using methotrexate in medical 
management of all ectopic pregnancies. In view of this, some experts have recom-
mended use of two-dose or multiple-dose regimens for such patients if they are 
not surgical candidates and medical management is warranted. Lipscomb et al. 
demonstrated that a high serum hCG level is the most important factor associated 
with failure of treatment with single-dose MTX protocol among women with tubal 
ectopic pregnancy [35].
Contraindications to methotrexate therapy [36, 37].
Absolute contraindications
1. Pregnancy of unknown location of only one evaluation.
2. Peptic ulcer disease.
3. Intrauterine pregnancy.
4. Sensitivity to methotrexate.
5. Breastfeeding.
6. Suspected tubal rupture.
7. Immunodeficiency.
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8. Active pulmonary disease.
9. Unwilling or unable to return for follow up visits.
Relative contraindications
1. Gestational sac >3.5 cm.
2. Embryonic cardiac motion.
3. Hepatic, renal, or hematologic dysfunction.
4. Serum beta hCG > 5000 mIU/ml.
11.2 Pre-treatment evaluation
Blood type, serum hCG (to be used as “Day 1” level).
Safety labs: full blood counts, complete metabolic panel consisting of AST/ALT, 
BUN/Cr, also to be repeated prior to additional MTX dosing.
11.3 Systemic methotrexate treatment protocol
Systemic methotrexate is usually given as a single-dose or two-dose or fixed 
multi-dose regimens. The single-dose regimen of 50 mg of methotrexate per body 
surface area (BSA, m2) is usually given only on the first day, then followed by serial 
monitoring of serum hCG on days 4 and 7. There is the possibility of repeating 
the same dose on days 7 and 11 if there is less than 15% drop in the levels of hCG 
between days 4 and 7 or between days 7 and 11. The two-dose regimen also uses 
50 mg of methotrexate per BSA (m2) and it is predetermined to be given on days 1 
and 4, then followed by serial serum hCG levels on days 4 and 7 or 11. There is also 
a possibility of repeating the same dose on days 7 and 11 if the drop in serum hCG 
levels between days 4 and 7 or days 7 and 11 are less than 15% respectively [36, 37].
The fixed multi-dose regimen uses 1 mg of methotrexate per kilogram body weight 
for a total of four doses given on alternate days; on the first, third, fifth, and seventh 
days while Folinic acid rescue is given on the second, fourth, sixth, and eighth days. This 
regimen requires serial serum hCG monitoring on the days of methotrexate injections 
until there is more than 15% drop from the previous level. Thereafter, continue weekly 
to every 4 weeks monitoring until the serum hCG levels is less than 5 mIU/ml [36, 37].
Methotrexate can also be injected locally into the gestational sac or in the fetal 
intracardiac space to enhance resolution of the pregnancy. This is usually done 
under ultrasound guidance and it is given in combination with systemic injection in 
various dosing regimens. Timor-Tritsch et al. suggested using a fixed dose of 75 mg 
of methotrexate; 25 mg intracardiac injection, 25 mg inside the gestational sac while 
the remaining 25 mg is given intramuscularly (Table 1).
11.4 Adjuvant medical treatments and other interventions
Give anti-D immunoglobulin injection if patient is rhesus negative.
Advise patient to discontinue folic acid supplementation during MTX treatment.
Avoid pelvic exams and sexual intercourse during treatment period.
Caution patients: to reduce gastrointestinal side-effects, avoid alcohol and non-
steroidal anti- inflammatory drugs (NSAIDs).
Avoid prolonged exposure to sun due to sun hypersensitivity while on MTX.
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Avoid new conception until serum hCG is undetectable.
Combination of systemic and local injection of methotrexate.
Timor-Tritsch recommendation of combined local and systemic injection:
A. 25 mg intragestational sac.
B. 25 mg into the placental site as the needle is being withdrawn.
C. 25 mg intramuscular prior to patient discharge from the hospital.
University of Illinois at Chicago protocol (unpublished):
A. Half dose of 50 mg/m2 BSA injected into the intragestational sac.
B. The remaining half dose of MTX is injected intramuscularly.
11.5 Potassium chloride
In the presence of cardiac activity, intracardiac injection of potassium chloride 
with 2 mEq/L under ultrasound guidance, and repeat until there is no longer 
Single-dose regimen
Days Activities performed
1 MTX 50 mg/m2 IM injection.
4 and 7 Measure hCG levels, a rise may be seen 
on Day 4 compared to baseline Day 1.
If ≥15% drop from Days 4 to 7, continue to follow weekly until hCG < 5 mIU/ml.
If <15% drop from Days 4 to 7, repeat MTX 50 mg/m2, repeat serum hCG on Day 11.
Two-dose regimen
Days Activities performed
1 MTX 50 mg/m2 IM injection.
4 MTX 50 mg/m2 IM injection and serum 
hCG level.
7 Serum hCG level, if ≥15% from Days 4 
to 7, continue weekly until hCG < mIU/
ml.
If <15% drop from Days 4 to 7, repeat MTX 50 mg/m2 and check hCG on Day 11; if ≥15% drop from Days 7 to 
11, continue to follow up weekly until hCG < 5 mIU/ml.
If <15% drop from Days 7 to 11, repeat MTX 50 mg/m2 and check hCG on Day 14; if ≥15% drop from Days 11 
to 14, continue to follow weekly until hCG < 5 mIU/ml.
Fixed multi-dose regimen
Days Activities performed
1, 3, 5, 7 MTX 1 mg/kg body weight.
2, 4, 6, 8 Folinic acid 0.1 mg/kg body weight.
Measure serum levels of hCG on MTX dose days; continue dosing until hCG decreases ≥15% from previous 
measurement.
Follow hCG until <5 mIU/ml.
MTX, methotrexate; hCG, human chorionic gonadotropin; IM, intramuscular.
Table 1. 
Different regimens of systemic methotrexate.
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cardiac activity. It usually requires 2–3 ml injections for the procedure. Potassium 
chloride can be used as a stand-alone treatment intervention in ectopic pregnancy 
or in combination with any of the methotrexate injection regimens. In a study of 
18 ectopic pregnancies with active embryonic cardiac activity, mean serum beta 
hCG levels of 33,412 IU/L and mean gestational age of 6 weeks and 6 days, 10 were 
assigned to KCL injection in the gestational sac while 8 were in the methotrexate 
group. There was no difference in time to resolution of ectopic pregnancies between 
those injected with KCL and those with methotrexate [38]. Verma et al. in a three-
case series of women with concurrent injection of local KCL and systemic injection 
of methotrexate, they demonstrated that complete resolution of ectopic pregnancy 
was achieved and surgery avoided in all 3 cases [39].
11.6 Newer treatment combinations
The use of selective progesterone reception modulator (Mifepristone) as an 
adjuvant for medical therapy has been tried. In a randomized trial by Rozenberg 
et al., there was no benefit from the systematic addition of mifepristone except 
in women with progesterone level of 10 ng/L or more [40]. However, in a larger 
study involving 72 patients; 30 with combined methotrexate-mifepristone and 42 
with methotrexate alone by Perdu et al., the failure rate was lower in the combined 
group, 1/30 (33.3%) compared to 11/42 (26.2%) in the methotrexate alone group 
[41]. Use of epidermal growth factor receptor inhibition in combination with 
methotrexate has been tried in an in vitro experiment and it showed inhibition of 
growth of placental cells. These results were confirmed in vivo in mouse models, 
and it revealed faster rate of fetal resorption when the two drugs were combined 
[42]. In a phase 1 nonrandomized open label study involving 12 women with 
ectopic pregnancy and 71 controls, the median level of serum beta hCG by day 7 
and the time of pregnancy resolution were significantly lower in the combined 
methotrexate and epidermal growth factor receptor blocker (gefitinib) compared 
with methotrexate alone group [43]. Hence, the future goal of medical management 
of extra-tubal ectopic pregnancies should be combination therapy ab initio with 
various methotrexate regimen.
12. Surgical management of non-tubal pregnancy
To ensure complete removal of a tubal ectopic pregnancy, a British surgeon, 
Robert Lawson Tait performed a laparotomy with ligation of ruptured tube and 
board ligament in April 1883. By the 1920s, laparotomy and ligation of the bleeding 
vessels with removal of the affected tube had become the standard of care, and it 
remained so until the late 1970s, when operative laparoscopy and salpingectomy 
replaced laparotomy and salpingectomy. For CSPs, nearly 50% of clinically diag-
nosed cases miscarriage during the first trimester but most of them will require 
additional surgical intervention to stop bleeding [44]. Surgical management of 
any ectopic pregnancy is associated with a high success rate; low complication rate 
and short post-treatment follow up [19]. In a national cohort study in the UK by 
Hart et al. of 102 cases of CSP, the success rates of expectant, medical and surgical 
management were 43% (9/21), 46% (7/15) and 96% (54/56), respectively. The 
complication rates were 15/21 (71%) with expectant, 9/15 (60%) with medical and 
20/56 (36%) with surgical management. Discharge from care (median number of 
days) was 82 (range 37–174) with expectant, 21 (range 10–31) with medical and 11 
(range 4–49) with surgical management [45].
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12.1 Suction curettage
This surgical intervention has been used to treat appropriately selected suitable 
patients with cervical ectopic or cesarean scar ectopic pregnancies. It is usually done 
under transabdominal or transrectal ultrasound guidance to ensure direct visualiza-
tion of the pregnancy sac during the procedure. This procedure has been used for 
cervical ectopic pregnancy (CEP) and CSP despite the fear of potential catastrophic 
hemorrhage that may warrant emergency hysterectomy or may result in significant 
maternal morbidity and mortality. When suction curettage is being considered as 
a treatment option, you also need to plan for possible use of adjuvant interventions 
to reduce excessive blood loss. Adjuvant methods that have used so far include but 
not limited to intracervical balloon tamponade, angiographic embolization, cervical 
cerclage, ligation of uterine arteries or local hysteroscopic endocervical resection 
of the gestational sac with local use of different substances. Among these, arterial 
embolization has gained more recognition than any other interventions to decrease 
potentially dangerous massive hemorrhage thought to be associated with suction 
curettage of CSP or cervical ectopic pregnancy. However, there have been reports of 
suction curettage used successfully to evacuate CEP or CSP with minimal complica-
tions. In a study by Jurkovic et al. of 232 women with CSP, suction curettage was 
an effective method for the treatment of 191 pregnancies implanted into the lower 
uterine segment cesarean section scar because of the 116 women who had a follow 
up visit, only 7 (6.0%), 95% CI 1.7–10.3% required a repeat surgical procedure for 
retained products of conception. It was associated with a low risk of blood transfu-
sion and hysterectomy. Of the 191 women, 9 (4.7%) required blood transfusion, 
95% CI 1.7–7.7, and 1 (0.5%) women had life-saving hysterectomy due to uncontrol-
lable intraoperative hemorrhage [46].
12.2 Wedge resection
Wedge resection of gestational sac can be used for many extra-tubal pregnan-
cies such as CSP, ovarian or cornual pregnancies. There have been multiple case 
reports on the safety and effectiveness of wedge resection of CSP via laparotomy. 
Wedge resection should be considered when the diagnosis is made early, there is no 
involvement of vital contiguous structures and need for preservation of fertility. 
In a case report by Vial et al. of 28 years old G3P2002 at 6 weeks gestation, wedge 
resection of the gestational mass via a Pfannenstiel incision resulted in complete 
resolution of the pregnancy and subsequent full-term pregnancy delivered by 
cesarean section [47]. Traditionally, wedge resections of the gestational sac or 
hysterectomy via laparotomy is the treatment of choice of interstitial or cornual or 
angular pregnancy. However, laparoscopic cornuotomy is the removal of ectopic 
pregnancy tissue with preservation of uterine architecture. This increases incidence 
of persistent and recurrent interstitial pregnancy, but can potentially maintain 
patient fertility and decrease risk of future uterine rupture. Patients with cornual 
resection are often delivered at 36–37 weeks of gestation via cesarean section in 
subsequent pregnancies because of their increased risk of uterine scar rupture. In 
a study of 29 patients by Liao et al., the incidence of subsequent uterine rupture 
and dehiscence was 30% [48]. However, there is still controversy in regards to the 
recommended surgical technique to treat interstitial pregnancies; cornual resection 
and cornuectomy are both important considerations.
A small ovarian ectopic pregnancy (OEP) or early bleeding can be treated 
with wedge resection or cystectomy with the intention to preserve some of 
the affected ovarian tissues. There have been anecdotal case reports of the 
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effectiveness of wedge resection in the treatment of OEP. A case report by 
Kraemer et al. showed a 29-year-old G1P0 at 8 weeks gestation with confirmed 
ovarian pregnancy and she was managed by laparoscopic wedge resection of 
the OEP. She subsequent was pregnant with a normal intrauterine pregnancy 
6 months after her surgery [49].
12.3 Laparotomy/laparoscopy in extra-tubal pregnancy
Directly visualization of the pregnancy via laparotomy or laparoscopy may 
be helpful in the definitive diagnosis of OEP and abdominal pregnancy. Surgical 
management of either of the two pregnancies is influenced by the size of the 
lesion, the proximity or attachment to vital organs, associated symptoms and the 
patient’s desire for future fertility [46]. Small OEP are usually treated conserva-
tively with wedge resection, enucleation, cystectomy, or trophoblast curettage 
with electrocoagulation or hemostatic suture to preserve fertility. However, large 
OEP may require oophorectomy when there are no apparent normal ovarian 
tissues left [47].
12.4 Adjuvant surgical interventions
The use of adjuvant interventions is to accelerate the efficacy of primary 
treatment or to minimize potential life-threatening complications. Intracervical 
balloon tamponade or cervical cerclage have been used during cervical curettage 
for cervical ectopic pregnancy to decrease bleeding. Direct ultrasound-guidance 
is helpful for all extra-tubal pregnancy to enable injection of methotrexate or KCL 
or hyperosmolar glucose into the gestational sac. Misoprostol and Methergine 
are uterotonic agents that cause vasoconstriction, thereby reducing the amount 
of blood loss during surgical intervention. Careful and appropriate use of these 
adjuvant treatments can improve successful outcome of primary treatment of 
extra-tubal pregnancy.
13. Conclusion
Ectopic pregnancy is the leading cause of first trimester maternal mortality, 
and it is mostly located in the fallopian tubes. When it is located outside the 
tubes, the need for high index of suspicious and prompt intervention is advised 
because the more advanced extra-tubal pregnancies can result in catastrophic 
hemorrhage or maternal death. Different surgical techniques that are unique to 
individual type of ectopic pregnancy, the use of methotrexate and combination 
therapy have all demonstrated proven benefits for the treatment of extra-tubal 
pregnancy.
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